Skip to main content
. 2016 May 5;24(2):120–123. doi: 10.1136/ejhpharm-2015-000840

Table 1.

Characteristics of cases with acute pancreatitis and controls from 2000 to 2011

Cases
(N=1449)
Controls
(N=2479)
Variable n (%) n (%) p Value*
Sex 0.89
 Female 549 (37.9) 945 (38.1)
 Male 900 (62.1) 1534 (61.9)
Age group (years) 0.80
 20–39 159 (11.0) 257 (10.4)
 40–64 723 (49.9) 1234 (49.8)
 65–84 567 (39.1) 988 (39.9)
Age (years), mean (SD)† 59.4 (14.3) 59.0 (14.6) 0.47
Losartan 0.75
 Never use 1300 (89.7) 2238 (90.3)
 Current use 52 (3.6) 90 (3.6)
 Late use 97 (6.7) 151 (6.1)
Other antihypertensive agents 0.006
 Never use 81 (5.59) 197 (7.95)
 Ever use 1368 (94.41) 2282 (92.05)
Comorbidities before index date
 Alcohol-related disease 154 (10.6) 191 (7.70) 0.002
 Biliary stone 383 (26.4) 563 (22.7) 0.009
 Cardiovascular disease 623 (43.0) 1048 (42.3) 0.66
 Chronic kidney disease 93 (6.42) 100 (4.03) <0.001
 Chronic obstructive pulmonary disease 364 (25.1) 596 (24.0) 0.45
 Diabetes mellitus 367 (25.3) 567 (22.9) 0.08
 Hepatitis B 68 (4.69) 55 (2.22) <0.001
 Hepatitis C 58 (4.00) 45 (1.82) <0.001
 Hyperparathyroidism‡ 7 (0.48) 1 (0.04) 0.005
 Hypertriglyceridaemia 41 (2.83) 28 (1.13) <0.001

Data are presented as the number of subjects in each group with percentages given in parentheses, or mean with SD given in parentheses.

2 test.

†t test comparing subjects with and without acute pancreatitis.

‡Fisher exact test.